Vaccination News Home Page

http://www.newscientist.com/news/news.jsp?id=ns99992446

Search
Free newsletter
NewScientist.com
NewScientist.com home page Latest science & technology news Hot topics in science Q & A's from everyday science Feedback, letters, book reviews, interview Links to other science sites Contents of this week's print edition Subscribe to New Scientist magazine New Scientist magazine archive Search 1000's of science and technology jobs
NEWS
All the latest news
Conference News
Search News
 
 



Top Stories
 
 
The World's No.1 Science & Technology News Service
 
 
Probiotic bacteria "treat eczema in babies"
 
00:01 24 June 02
 
NewScientist.com news service
 
Probiotic bacteria given to babies with eczema at weaning can alleviate their symptoms, according to Finnish research.

The team at the University of Turku, Finland, analysed the gut flora of 13 babies with eczema. Stool samples were taken from all the babies before weaning and analysed for levels of "unfriendly" gut organisms, particularly Escherichia coli and other human gut pathogens.

Previous work has shown that high levels of these bacteria can stimulate the immune system to boost production of IgE antibodies, which are involved in causing allergic reactions.

The babies were weaned onto hydrolysed whey formula feed. Seven were also given supplements of Bifidobacterium lactis - a common benign bacterium found in the gut of healthy people. After four months, the infants' gut bacteria and IgE concentrations were analysed.

The babies receiving the probiotic supplements had significantly reduced levels of E. coli and bacteriodes in their stool samples - and significantly lower levels of IgE antibodies.

Simon Murch, a paediatric gastroenterologist at the Royal Free Hospital in London says the results are "interesting", but not unexpected. But, he says, the findings conflict with other research on allergy and gut bacteria.

One unpublished 20-year follow-up study in Prague has shown that E. coli given to babies at birth reduces allergy later in life. "Two E. coli formulae are commercially available in Czechoslovakia and are frequently given to infants there," Murch told New Scientist.

Journal reference: Gut (vol 51, p 51)

 

Gaia Vince


 

This story is from NewScientist.com's news service - for more exclusive news and expert analysis every week subscribe to New Scientist print edition.

 


 

Print this article Send to a friend


 

 
  For what’s in New Scientist magazine this week see Print Edition
 
  Search the Archive for more stories like this, originally published in the Print Edition
 
  Subscribe to New Scientist Print Edition
 
  Correspondence about this story should be directed to onlinenews@newscientist.com
 
  Sign up for our free newsletter
 
 
Subscribe to New Scientist magazine


 
Online Conference News
 
  British Psychological Society
 



 
More on this story
 
Related Stories
 
 
 
 
 
For more related stories
search the print edition Archive
 
 
Weblinks
 
 
 
 



Elsewhere today
All the best science stories from the web
Babies make eye contact in 48 hours
Telegraph, UK (free registration required)


NewScientist Archive: Free to Subscribers

priceline - Save up to 40% on Airline Tickets
 
Departure City:    Arrival City:   
 
 
 
About newscientist.com •  Subscribe •  Contact Us •  FAQ •  Media Information •  Disclaimer •  Terms and Conditions • 
Site Map •  Privacy Policy  © Copyright Reed Business Information Ltd.

Click here ...

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.